Microbot Medical Expands Collaboration with Corewell Health
Microbot Medical Inc. (NASDAQ: MBOT), a leader in cutting-edge medical technologies, has announced an important Phase 2 collaboration agreement with Corewell Health. This new phase builds on the successful results from Phase 1, which evaluated the effectiveness of the LIBERTY Endovascular Robotic System as a reliable platform for remote telesurgery.
Objectives of Phase 2
The main aim of Phase 2 is to enhance and showcase the advanced telesurgery capabilities through simulated interventional procedures conducted at two locations within the Corewell Health system. These facilities are conveniently located just 5 miles apart, allowing for efficient evaluation and testing of the LIBERTY system's remote functionalities.
Significant Developments from Phase 1
The first phase of this collaboration demonstrated the technical success and potential uses of LIBERTY in various endovascular procedures. It confirmed that LIBERTY can effectively support remote telesurgery, opening the door for innovative methods in cardiovascular care.
Leadership and Research Contributions
This collaboration is led by Dr. Ryan Madder, a highly experienced interventional cardiologist and the Section Chief at Corewell Health's Cardiac Cath Lab. After completing Phase 1, Dr. Madder and his team made significant contributions to the field with their publication in a prominent cardiology journal, highlighting the advanced techniques employed in coronary guidewire and stent delivery.
Future of Remote Telesurgery
Harel Gadot, CEO of Microbot Medical, shared his enthusiasm for the project, stating, "Incorporating telesurgery capabilities is a crucial part of our strategic vision for LIBERTY. We believe that increasing access to medical care, particularly in remote areas, aligns with our goals, and we are excited to advance this next phase of development alongside Corewell Health and Dr. Madder." This reflects the company's dedication to transforming access to surgical care.
The LIBERTY Endovascular Robotic System
The LIBERTY Endovascular Robotic Surgical System is designed to revolutionize surgical practices by reducing the need for large surgical equipment, which can often limit accessibility and increase radiation exposure for healthcare professionals. This innovative method promises significant benefits for patient care and operational efficiency.
About Microbot Medical Inc.
Microbot Medical is a clinical-stage medical device company focused on developing groundbreaking micro-robotic technologies. These advancements aim to improve patient outcomes and enhance accessibility by navigating both natural and artificial pathways within the human body.
Commitment to Innovation
The company's vision includes making remote operations a viable option for endovascular procedures, potentially democratizing access to advanced surgical techniques for patients around the globe. As they continue to advance the LIBERTY system, they expect to redefine surgical practices, aligning with their mission to innovate in the medical field.
Frequently Asked Questions
What is the LIBERTY Endovascular Robotic System?
The LIBERTY Endovascular Robotic System is an advanced robotic technology designed to enhance remote surgical procedures, especially in endovascular interventions.
What are the goals of the Phase 2 collaboration?
Phase 2 aims to further develop and demonstrate telesurgery capabilities through simulated procedures at different sites within Corewell Health.
Who is leading the project?
Dr. Ryan Madder, the Section Chief of Interventional Cardiology at Corewell Health, is leading the collaboration project.
How does LIBERTY improve surgical access?
LIBERTY reduces the need for bulky surgical equipment, minimizes radiation exposure, and addresses the challenges associated with providing care in remote environments.
What is Microbot Medical's vision?
Microbot Medical aims to transform surgical practices through innovative technologies that enhance accessibility to life-saving procedures, particularly for patients in underserved areas.
